GS0411: Education, namely, providing classes, courses, seminars, workshops, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing of training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing entertainment in the nature of exhibitions, live shows, online non-downloadable video and non-downloadable films via video-on-demand transmission services, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; educational services, namely, providing know-how transfer training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing online electronic publications, not downloadable, in the nature of books, magazines, and newsletters related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; publication of texts, other than publicity texts, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; arranging and conducting of conferences, congresses and symposium related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field
GS0051: Pharmaceutical and veterinary preparations for treating cancer, myocardium infarction and malaria; sanitary preparations for medical purposes; biological preparations for medical purposes for the treatment of cancer, myocardium infarction and malaria; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer, myocardium infarction and malaria; chemico-pharmaceutical preparations for the treatment of cancer, myocardium infarction and malaria; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of cancer, myocardium infarction and malaria; pharmaceuticals in the nature of anti-cancer preparations
D10000: "NERVIANO MEDICAL SCIENCES" AND "GROUP"
GS0421: Scientific, technological, analysis and research services, namely, scientific research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; medical and scientific research, namely, conducting clinical trials for others in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control for others in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies
Case File Event Statements
7/10/2023 - 10 months ago
34 - FINAL DECISION TRANSACTION PROCESSED BY IBType:FINO
6/10/2023 - 11 months ago
33 - GENERIC MADRID TRANSACTION SENT TO IBType:XXSS
6/10/2023 - 11 months ago
32 - GENERIC MADRID TRANSACTION CREATEDType:XXCR
6/7/2023 - 11 months ago
31 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IBType:FICR
3/7/2023 - a year ago
30 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC
3/7/2023 - a year ago
29 - REGISTERED-PRINCIPAL REGISTERType:R.PR
12/21/2022 - a year ago
28 - NOTIFICATION PROCESSED BY IBType:GPNX
12/20/2022 - a year ago
27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
12/20/2022 - a year ago
26 - PUBLISHED FOR OPPOSITIONType:PUBO
11/30/2022 - a year ago
25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IBType:OPNS
11/30/2022 - a year ago
24 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IBType:OP2R
11/30/2022 - a year ago
23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
11/13/2022 - a year ago
22 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
9/27/2022 - a year ago
21 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
9/27/2022 - a year ago
20 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
9/27/2022 - a year ago
19 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA